65 related articles for article (PubMed ID: 16263829)
1. Nuclear receptor coactivator-3 alleles are associated with serum bioavailable testosterone, insulin-like growth factor-1, and vertebral bone mass in men.
Sheu YT; Zmuda JM; Cauley JA; Moffett SP; Rosen CJ; Ishwad C; Ferrell RE
J Clin Endocrinol Metab; 2006 Jan; 91(1):307-12. PubMed ID: 16263829
[TBL] [Abstract][Full Text] [Related]
2. IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men.
Rucker D; Ezzat S; Diamandi A; Khosravi J; Hanley DA
Clin Endocrinol (Oxf); 2004 Apr; 60(4):491-9. PubMed ID: 15049965
[TBL] [Abstract][Full Text] [Related]
3. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
Montgomery KG; Chang JH; Gertig DM; Dite GS; McCredie MR; Giles GG; Southey MC; Hopper JL; Campbell IG
Breast Cancer Res; 2005; 7(3):R353-6. PubMed ID: 15987430
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
5. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density.
Rosen CJ; Kurland ES; Vereault D; Adler RA; Rackoff PJ; Craig WY; Witte S; Rogers J; Bilezikian JP
J Clin Endocrinol Metab; 1998 Jul; 83(7):2286-90. PubMed ID: 9661596
[TBL] [Abstract][Full Text] [Related]
6. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.
Van Pottelbergh I; Goemaere S; Kaufman JM
J Clin Endocrinol Metab; 2003 Jul; 88(7):3075-81. PubMed ID: 12843146
[TBL] [Abstract][Full Text] [Related]
7. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
[TBL] [Abstract][Full Text] [Related]
8. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
[TBL] [Abstract][Full Text] [Related]
9. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
[TBL] [Abstract][Full Text] [Related]
10. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study.
Greendale GA; Edelstein S; Barrett-Connor E
J Bone Miner Res; 1997 Nov; 12(11):1833-43. PubMed ID: 9383688
[TBL] [Abstract][Full Text] [Related]
11. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.
Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770
[TBL] [Abstract][Full Text] [Related]
12. Lack of association of anabolic hormone status and muscle strength with regional and whole body bone mineral density in healthy men aged 60-79 years.
Taaffe DR; Cooper CS; Holloway L; Duret C; Marcus R
Aging (Milano); 1999 Feb; 11(1):4-11. PubMed ID: 10337436
[TBL] [Abstract][Full Text] [Related]
13. Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats.
Huhtaniemi IT; Pye SR; Limer KL; Thomson W; O'Neill TW; Platt H; Payne D; John SL; Jiang M; Boonen S; Borghs H; Vanderschueren D; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC;
J Clin Endocrinol Metab; 2009 Jan; 94(1):277-84. PubMed ID: 18840639
[TBL] [Abstract][Full Text] [Related]
14. Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight.
Martínez Díaz-Guerra G; Hawkins F; Rapado A; Ruiz Díaz MA; Díaz-Curiel M
Osteoporos Int; 2001; 12(3):178-84. PubMed ID: 11315235
[TBL] [Abstract][Full Text] [Related]
15. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study.
Szulc P; Munoz F; Claustrat B; Garnero P; Marchand F; Duboeuf F; Delmas PD
J Clin Endocrinol Metab; 2001 Jan; 86(1):192-9. PubMed ID: 11232000
[TBL] [Abstract][Full Text] [Related]
16. A common promotor variant in the cytochrome P450c17alpha (CYP17) gene is associated with bioavailability testosterone levels and bone size in men.
Zmuda JM; Cauley JA; Kuller LH; Ferrell RE
J Bone Miner Res; 2001 May; 16(5):911-7. PubMed ID: 11341336
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men.
Gennari L; Merlotti D; Martini G; Gonnelli S; Franci B; Campagna S; Lucani B; Dal Canto N; Valenti R; Gennari C; Nuti R
J Clin Endocrinol Metab; 2003 Nov; 88(11):5327-33. PubMed ID: 14602769
[TBL] [Abstract][Full Text] [Related]
18. The relationship between sex steroids, bone turnover and vertebral fracture prevalence in asymptomatic men.
El Maghraoui A; Ouzzif Z; Mounach A; Ben-Ghabrit A; Achemlal L; Bezza A; Ghozlani I
Bone; 2011 Oct; 49(4):853-7. PubMed ID: 21723429
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I in men with idiopathic osteoporosis.
Kurland ES; Rosen CJ; Cosman F; McMahon D; Chan F; Shane E; Lindsay R; Dempster D; Bilezikian JP
J Clin Endocrinol Metab; 1997 Sep; 82(9):2799-805. PubMed ID: 9284699
[TBL] [Abstract][Full Text] [Related]
20. Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism.
Ferlin A; Schipilliti M; Vinanzi C; Garolla A; Di Mambro A; Selice R; Lenzi A; Foresta C
J Clin Endocrinol Metab; 2011 Apr; 96(4):E739-45. PubMed ID: 21270324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
